Procter & Gamble's organic revenue in the second quarter was lower than estimated.

Procter & Gamble's organic revenue growth was 0% in the second quarter, estimated to be 0.54%. Core earnings per share for the second quarter were $1.88, the same as the previous year, and slightly below the estimated $1.86. Net sales for the second quarter were $22.1 billion, a 1.5% increase year-on-year, with an estimated $22.3 billion. Procter & Gamble continues to forecast organic revenue growth of 0% to 4% for the full year, while the market predicts a growth of 1.7%. The company also maintains its forecast for core earnings per share to increase by 0% to 4%, with an estimate of $6.83 to $7.09, compared to the market estimate of $6.97. Procter & Gamble's pre-market stock fell by nearly 1%.